Join to View Full Profile
350 Parnassus AveSan Francisco, CA 94117
Phone+1 415-353-2318
Fax+1 415-353-2407
Dr. Bissell is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 1970 - 1973
Boston University Medical CenterResidency, Internal Medicine, 1968 - 1970- Boston University Medical CenterInternship, Transitional Year, 1967 - 1968
Harvard Medical SchoolClass of 1967
Certifications & Licensure
CA State Medical License 1970 - 2020
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
Clinical Trials
- Longitudinal Study of the Porphyrias Start of enrollment: 2010 Nov 01
- Clinical Diagnosis of Acute Porphyria Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 58 citationsEfficacy and safety of givosiran for acute hepatic porphyria: 24-month interim analysis of the randomized phase 3 ENVISION studyPaolo Ventura, Herbert L. Bonkovsky, Laurent Gouya, Paula Aguilera-Peiró, D. Montgomery Bissell
Liver International. 2021-10-30 - 33 citationsHepatocellular Carcinoma in Acute Hepatic Porphyrias: Results from the Longitudinal Study of the U.S. Porphyrias Consortium.Behnam Saberi, Hetanshi Naik, Jessica Overbey, Angelika Erwin, Karl E. Anderson
Hepatology. 2021-05-01 - 355 citationsPhase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent PorphyriaManisha Balwani, Eliane Sardh, Paolo Ventura, Paula Aguilera Peiró, David C. Rees
The New England Journal of Medicine. 2020-06-10
Grant Support
- Liver CenterNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2005
- Cellular Pathophysiology Of Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2002
- Core--Liver Cell CultureNational Institute Of Diabetes And Digestive And Kidney Diseases1995–2001
- Regulation Of The Fibronectin Gene In Liver CellsFogarty International Center1996–1998
- Cellular Pathophysiology Of Hepatic FibrosisNational Institute Of Diabetes And Digestive And Kidney Diseases1986–1994
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
